A vial of the Moderna's COVID-19 vaccine, Bivalent. Though the shots are free to pretty much anyone who wants one in the U.S. as long as federal stockpiles hold out, the next update of the vaccine might be costly for some people who lack health insurance. RINGO CHIU/AFP via Getty Images hide caption
A bottle of Johnson & Johnson baby powder is displayed on a table. J&J pulled its iconic Johnson's baby powder off the shelves in the U.S. in 2020. Justin Sullivan/Getty Images hide caption
An arrangement of pills of the opioid oxycodone-acetaminophen in New York. Idaho officials on Friday agreed to a $119 million settlement with drugmaker Johnson & Johnson and three major distributors over their role in the opioid addiction crisis. Patrick Sison/AP hide caption
Hope Schiller Wilt (left) and her daughter, Hanna Wilt, outside her home on Nov. 19, 2021, in Manasquan, N.J. The family plans to continue her lawsuit. "It's what she wanted," her mother said. Jackie Molloy for NPR hide caption
Johnson & Johnson's baby powder is displayed on a table in this photo illustration. A federal judge has allowed Johnson & Johnson's spinoff of a unit to proceed with a controversial bankruptcy. Justin Sullivan/Getty Images hide caption
Nurse Sandra Lindsay celebrates after receiving her COVID-19 Pfizer vaccine booster at Long Island Jewish Medical Center in New York in October. Lindsay was the first person known to receive a COVID vaccine in the United States vaccination campaign — on Dec. 14, 2020. Her vaccination card is displayed at the COVID-19 exhibit in the Smithsonian Museum of American History. Lev Radin/Pacific Press via Getty Images hide caption
Ari Blank got a comforting hand-squeeze from his mom in May as he was vaccinated against COVID-19 in Bloomfield Hills, Mich. This week, the Food and Drug Administration authorized the use of Pfizer's vaccine in even younger kids — ages 5 to 11. Jeff Kowalsky/AFP via Getty Images hide caption
A health care worker administers a Pfizer-BioNTech COVID-19 vaccine Thursday at Life of Hope Center in New York City. Michael M. Santiago/Getty Images hide caption
In this photo illustration, a container of Johnson's baby powder sits on a table in 2019. Justin Sullivan/Getty Images hide caption
Johnson & Johnson has asked U.S. regulators to allow booster shots of its COVID-19 vaccine. David Zalubowski/AP hide caption
The COVID-19 vaccine from Johnson & Johnson was a one-shot regime. But data shows that people who got the shot may have waning immunity, and some doctors say a second shot would be a good idea. Stephen Zenner/Getty Images hide caption
Johnson & Johnson shared data from the Phase 3 trial of its booster shot on Tuesday indicating a booster shot at six months provided a 12-fold increase in antibodies. Eva Marie Uzctegui/Bloomberg via Getty Images hide caption
A nurse fills a syringe with Johnson & Johnson's COVID-19 vaccine at a clinic in Pasadena, Calif., on Thursday. Robyn Beck/AFP via Getty Images hide caption